Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.9 USD | +1.98% | -2.42% | +31.08% |
Business Summary
Number of employees: 65
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 30/20/30 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | - | 08/11 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/20/01 |
John McHutchison
BRD | Director/Board Member | 66 | 06/19/06 |
Shannon Ryan
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | - | |
General Counsel | - | 01/22/01 | |
Nicole White
PRN | Corporate Officer/Principal | - | 17/20/17 |
Human Resources Officer | - | 01/17/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 60 | 14/17/14 |
Gina Consylman
BRD | Director/Board Member | 52 | 20/20/20 |
William Ringo
CHM | Chairman | 78 | 01/14/01 |
Anthony Altig
BRD | Director/Board Member | 68 | 01/12/01 |
Jason Okazaki
CEO | Chief Executive Officer | 48 | 30/20/30 |
Michael Houghton
BRD | Director/Board Member | 73 | 19/21/19 |
John McHutchison
BRD | Director/Board Member | 66 | 06/19/06 |
Tomas Cihlar
BRD | Director/Board Member | - | 07/12 |
Director/Board Member | 60 | 20/21/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,482,752 | 3,667,926 ( 66.90 %) | 0 | 66.90 % |
Company contact information
Assembly Biosciences, Inc.
Two Tower Place 7th floor
94080, South San Francisco
+833 509 4583
http://www.assemblybio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.08% | 69.36M | |
+4.06% | 70.44B | |
+12.68% | 8.94B | |
-14.44% | 4.75B | |
+41.60% | 4.5B | |
+5.96% | 3.85B | |
+23.46% | 2.38B | |
-19.32% | 2.34B | |
-27.04% | 2.2B | |
+7.97% | 1.96B |
- Stock Market
- Equities
- ASMB Stock
- Company Assembly Biosciences, Inc.